Pacira BioSciences PCRX
NASDAQ PCRX
$25.65 +0.26 (+1.02%)
At close: Sep 29, 2026 · 4:00 PM EDT

Pacira BioSciences (PCRX) Acquisitions (2019 - 2026)

Updated

Pacira BioSciences' Acquisitions was $335,000 in Q1 2026, down 98.0% from $16.7 million a year earlier.

Analysis

Pacira BioSciences (PCRX) Acquisitions (2019 - 2026) Analysis & Trends

For FY2025, Acquisitions at Pacira BioSciences came in at $16.7 million.

  • Acquisitions shows a four-year compound annual growth rate of -55.3% (FY2021 to FY2025).
  • In earlier years, Acquisitions was $420.04 million in FY2021.
  • The Q1 2026 figure marks the lowest quarterly Acquisitions since Q4 2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Acquisitions (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn -17.24 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn -
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -23.00 Mn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn -
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 11.21 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn -
10 Pacira BioSciences 1.01 Bn 73.12 Mn 148.24 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 335,000.00
Mar 31, 2025 16.70 Mn
Dec 31, 2019 -992,000.00
API Access

Pacira BioSciences Acquisitions API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=acquisitions&ticker=PCRX&period=max&api_key=YOUR_API_KEY